Insider trade

Tyra Biosciences (TYRA)CEO sold ~$642K

Todd Harris, CEO at Tyra Biosciences, sold ~$642K of Tyra Biosciences shares.

~$642K
Approx. value · 24K sh @ $26.23: 1.44M
Holds after · shares reported

Traded: Oct 16, 2024
Filed: Oct 18, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Sep 30, 2024InsiderCEO sold ~$12K of TYRA shares in the open market
Oct 15, 2024InsiderCEO sold ~$244K of TYRA shares in the open market
Oct 16, 2024 · this disclosureInsiderCEO sold ~$642K of TYRA shares in the open market

What came next

Oct 16, 2024Insider · 1 personInsiders: 2 sales (~$229K)
Oct 17, 2024Insider · 1 personInsiders: 2 sales (~$398K)
Oct 18, 2024InsiderCEO sold ~$1.18M of TYRA shares in the open market
Oct 21, 2024Insider · 1 personInsiders: 2 sales (~$532K)
Oct 30, 2024Insider · 2 peopleInsiders: 1 purchase (~$152K), 2 sales (~$179K)
Oct 31, 2024Insider · 1 personInsiders: 2 sales (~$1.6M)
Nov 1, 2024Insider · 1 personInsiders: 4 sales (~$455K)
Nov 4, 2024Insider · 1 personInsiders: 2 sales (~$18K)
Nov 5, 2024Insider · 1 personInsiders: 2 sales (~$176K)
Nov 6, 2024Insider · 1 personInsiders: 2 sales (~$902K)
Nov 7, 2024Insider · 1 personInsiders: 2 sales (~$383K)
Nov 8, 2024InsiderDirector purchased ~$19.8M of TYRA shares in the open market
Nov 25, 2024Insider · 1 personInsiders: 2 sales (~$89K)
Jan 16, 2025Insider · 1 personInsiders: 2 sales (~$127K)
Jan 17, 2025Insider · 1 personInsiders: 2 sales (~$218K)
Jan 21, 2025InsiderDirector sold ~$65K of TYRA shares in the open market
Jan 23, 2025InsiderDirector sold ~$78K of TYRA shares in the open market
Feb 5, 2025Insider · 1 personInsiders: 2 sales (~$74K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Tyra Biosciences

For Tyra Biosciences, OQRO holds 5 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TYRA page.

Other recent filings by Todd Harris, President and CEO

The full history of Todd Harris, President and CEO is on the profile page.

How this filing works

Other disclosures at Tyra Biosciences

Everything OQRO holds on this company is on its TYRA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data